Related Experiment Video
Updated: May 24, 2026

Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation
Published on: January 16, 2019
Genetic testing of inherited arrhythmias
1Molecular Cardiology Laboratories, IRCCS Fondazione Salvatore Maugeri, Via Maugeri 10, 27100, Pavia, Italy. carlo.napolitano@nyumc.org
Insights
Inherited arrhythmias, including those causing sudden cardiac death, stem from genetic mutations affecting heart function. Genetic diagnosis and risk stratification are crucial for managing these conditions.
Area of Science:
- Cardiology
- Genetics
- Molecular Biology
Background:
- Inherited cardiac conditions often manifest as syncope or sudden death due to ventricular tachyarrhythmia.
- Genetic mutations can directly impact cardiac excitability in structurally normal hearts or cause myocardial abnormalities, as seen in arrhythmogenic right ventricular cardiomyopathy and hypertrophic cardiomyopathy.
Purpose of the Study:
- To review known genes and mechanisms in inherited arrhythmias.
- To discuss the clinical utility, limitations, and future of genetic screening for these conditions.
Main Methods:
- Literature review of genetic discoveries in inherited arrhythmias from the 1990s to the present.
- Analysis of genotype-phenotype correlations and genotype-based risk stratification.
Main Results:
- Significant advancements in understanding major genes linked to arrhythmia risk and sudden death.
- Established genetic diagnosis, genotype-phenotype correlation, and risk stratification schemes are now in clinical practice.
Conclusions:
- Genetic factors are central to the pathogenesis of inherited arrhythmias.
- Genetic screening offers diagnostic and risk-stratification benefits but requires careful consideration of its limitations and potential threats.
Abstract:
Syncope and risk of sudden death due to ventricular tachyarrhythmia are the common manifestations of several inherited disorders. Abnormalities of the genetic makeup may directly affect proteins controlling cardiac excitability in a structurally normal heart. Other diseases manifest primarily with ventricular arrhythmias even though the genetic mutations cause structural abnormalities of the myocardium. This is the case of arrhythmogenic right ventricular cardiomyopathy and hypertrophic cardiomyopathy. Groundbreaking discoveries, starting from the 1990s until the beginning of the current decade, have provided fundamental knowledge on the major genes that confer an increased risk of arrhythmias and sudden death. Stems of such knowledge are the availability of genetic diagnosis, genotype-phenotype correlation, and genotype-based risk stratification schemes currently used in the clinical practice. This review provides a concise description of the known genes and key mechanisms involved in the pathogenesis of inherited arrhythmias. In addition, we outline possibilities, limitations, advantages, and potential threats of genetically screening for these genes.
Related Concept Videos
Dysrhythmias V: Evaluating Dysrhythmias
Mechanism of Cardiac Arrhythmias
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
Disturbances in Heart Rhythm
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
Electrocardiogram
Three major waveforms are present in a typical ECG recording: the P wave, the QRS complex, and the T...
ECG Interpretation of Arrhythmias I: Sinus Arrhythmias
Types of Arrhythmias
Sinus Node Arrhythmias
Sinus Bradycardia: Originating from the sinoatrial (SA) node, sinus bradycardia involves slower impulses, resulting in a heart rate of less than 60 beats per minute (bpm). Causes include sleep, vagal stimulation, beta-blockers, hypothyroidism, and...

